Letters in Drug Design & Discovery

Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, research articles, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity ...read more

  • ISSN (Print): 1570-1808
  • ISSN (Online): 1875-628X
  • Volume: 22
  • Issues: 16, 2025
1.2
1.8
Letters in Drug Design & Discovery
Review Article
Reactive Oxygen Species (ROS): Key Components in Cancer Therapies

Pp: 215-222

Volume: 22 Issues: 2

Authors:Biswa Mohan Sahoo*, Bimal Krishna Banik, Preetismita Borah and Adya Jain

DOI: 10.2174/1871520614666140624110458

Published on:September 12, 2023

Add to Wishlist Purchase PDF
Review Article
Reactive Oxygen Species (ROS): Key Components in Cancer Therapies

Pp: 215-222

Volume: 22 Issues: 2

Authors:Biswa Mohan Sahoo*, Bimal Krishna Banik, Preetismita Borah and Adya Jain

DOI: 10.2174/1871520614666140624110458

Published on:September 12, 2023

Add to Wishlist Purchase PDF
Review Article
Reactive Oxygen Species (ROS): Key Components in Cancer Therapies

Pp: 215-222

Volume: 22 Issues: 2

Authors:Biswa Mohan Sahoo*, Bimal Krishna Banik, Preetismita Borah and Adya Jain

DOI: 10.2174/1871520614666140624110458

Published on:September 12, 2023

Add to Wishlist Purchase PDF
Review Article
Reactive Oxygen Species (ROS): Key Components in Cancer Therapies

Pp: 215-222

Volume: 22 Issues: 2

Authors:Biswa Mohan Sahoo*, Bimal Krishna Banik, Preetismita Borah and Adya Jain

DOI: 10.2174/1871520614666140624110458

Published on:September 12, 2023

Add to Wishlist Purchase PDF

Share Your Research

Join our call for papers and contribute to the ever-evolving world of science.
Share your research with a global audience.

Calls for Papers

Special issues and article collections

Endorsement(s)

"Letters in Drug Design & Discovery should be available in every library in the pharmaceutical industry and in universities."

R. F. Borne, Associate Director
Laboratory for Applied Drug Design and Synthesis, The University of Mississippi, USA

Archived in

Related Journals

Related Books